Gain Therapeutics GANX
NASDAQ GANX
$1.29 +0.10 (+8.40%)
At close: Oct 22, 2026 · 4:00 PM EDT

Gain Therapeutics (GANX) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Gain Therapeutics' Depreciation & Amortization (CF) came in at $27,170 for Q2 2026, up 21.7% from $22,328 a year earlier and up 27.5% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Gain Therapeutics reported Depreciation & Amortization (CF) of $99,531, up 15.8% year-over-year; for FY2025, it came in at $94,046, up 11.9% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last five years, with a five-year compound annual growth rate of 57.9% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $84,071 in FY2024 (+0.6%), $83,579 in FY2023 (+30.3%), $64,168 in FY2022 (+314.4%) and $15,484 in FY2021 (+61.4%).
  • The five-year range for quarterly Depreciation & Amortization (CF) is $4,135 (Q3 2021) to $28,241 (Q4 2025).
  • Year-over-year, Depreciation & Amortization (CF) has increased for six consecutive quarters, with growth averaging 8.5% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2022 (growth of 827.8%), and the weakest in Q4 2024 (a decline of 9.7%).
  • Business Quant data shows GANX's Depreciation & Amortization (CF) at $21,303 (Q1 2026), $28,241 (Q4 2025) and $22,817 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 Gain Therapeutics 54.89 Mn -4.40 Mn - 27,170.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 27,170.00
Mar 31, 2026 21,303.00
Dec 31, 2025 28,241.00
Sep 30, 2025 22,817.00
Jun 30, 2025 22,328.00
Mar 31, 2025 20,660.00
Dec 31, 2024 21,307.00
Sep 30, 2024 21,643.00
Jun 30, 2024 20,593.00
Mar 31, 2024 20,528.00
Dec 31, 2023 23,589.00
Sep 30, 2023 20,509.00
Jun 30, 2023 20,239.00
Mar 31, 2023 19,242.00
Dec 31, 2022 18,110.00
Sep 30, 2022 17,828.00
Jun 30, 2022 20,021.00
Mar 31, 2022 8,209.00
Dec 31, 2021 5,788.00
Sep 30, 2021 4,135.00
API Access

Gain Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=GANX&period=max&api_key=YOUR_API_KEY